Send to a Friend Font Size: Increase Decrease

William Ackman

William Ackman's Portfolio

Ticker	# of Shares	Price	Value
	15,095,528	$195.32	$2,948,458,529
GOOG	9,377,195	$298.30	$2,797,217,269
HLT	9,332,853	$298.64	$2,787,163,220
LOW	7,468,850	$251.89	$1,881,328,627
QSR	23,348,135	$73.98	$1,727,295,028
HHC	16,570,228	$78.76	$1,305,071,158
GOOGL	2,185,000	$298.52	$652,266,200
CMG	953,608	$35.37	$33,729,115
View Additional Portfolio Information »

Bill Ackman runs hedge fund Pershing Square Capital, which he started in 2003 following the dissolution of Gotham Partners.

Ackman is a value investor with an activist bent. Activist investors agitate management for changes. He owns large positions in Target (NYSE: TGT) and Borders (NYSE: BGP). He has also been involved in activist situations at Wendy's (NYSE: WEN) and McDonald's (NYSE: MCD).

Ackman proved his acumen as a short seller in 2007/2008 as short positions he held in MBIA (NYSE: MBI) and Ambac (NYSE: ABK) proved to be big winners due to the credit crunch.

In July 2008, Ackman said he was short the common stock of Fannie Mae (NYSE: FNM) and Freddie Mac (NYSE: FRE). Ackman also laid out a plan to reorganize the GSEs, which would wipe out the common shareholders.

Login to help us fill in information about this entity.

View Older Stories View More Recent Stories

Apr 14, 2016 07:30AM S&P Downgrades Valeant Pharma (VRX) to 'B'; Notes Escalation in Near-Term Default Risk
Apr 13, 2016 04:24PM Hedge funds' billion-dollar club loses members in 2015
Apr 13, 2016 01:31PM Herbalife (HLF) on Watch Ahead of 'Betting on Zero' Premiere
Apr 8, 2016 07:35AM Wall St. ends higher but indexes post weekly losses
Apr 8, 2016 06:29AM Ackman Shoots Down Idea of Valeant (VRX) Unloading Bausch & Lomb
Apr 7, 2016 07:55AM Valeant gets extra month to file annual report
Apr 6, 2016 04:37PM Pershing Square NAV/Share Up Modestly in April; YTD Return Ticked Higher Last Week
Apr 6, 2016 11:27AM Valeant Pharma (VRX) Ramps to Session Highs
Apr 6, 2016 10:32AM Ackman says Valeant may find new CEO in weeks, not months
Apr 6, 2016 10:10AM Pershing Square's Ackman Says Valeant (VRX) was Passive Holding Until Recent, Board Focused on CEO Search
Apr 6, 2016 06:09AM Ackman to face investor grilling after record quarterly loss
Apr 1, 2016 06:43PM Ackman's fund falls 7 percent in March, hurt by Valeant
Mar 31, 2016 12:15PM Regulator orders drugmaker Valeant management to cease trading
Mar 30, 2016 06:00AM Historic 10-Year Anniversary of a Celebration of Heroes, Heart and Hope Gala in New York City Commemorating ‘A Decade of Difference’
Mar 28, 2016 02:31PM Ackman's Amends Valeant Pharma (VRX) 13D to Add Director Consent for MCTO
Mar 28, 2016 11:49AM Valeant CEO subpoenaed to testify before U.S. Senate panel
Mar 25, 2016 02:24PM Senate's request for info from Ackman related to Valeant: source
Mar 25, 2016 10:17AM Fitch: Pershing Square Holdings' 'BBB+' Ratings Not Yet Impacted by Valeant Decline
Mar 24, 2016 05:50PM Ackman Doesn't See 'Slap on the Wrist' for Herbalife (HLF)
Mar 24, 2016 05:42PM Ackman Sees Confidence Restored in Valeant Pharma (VRX) After 10-K Filed, New Leadership Identified
Mar 24, 2016 04:31PM Ackman's hedge fund cooperating with U.S. on drug pricing probe: letter
Mar 23, 2016 10:13AM Ackman Skipping Sohn Investment Conference to Focus on Valeant (VRX)
Mar 23, 2016 07:02AM The Howard Hughes Corporation® Issues Letter to Shareholders
Mar 22, 2016 10:39AM Valeant Pharma (VRX) Gains as Ackman Gets Hands On
Mar 21, 2016 11:34AM Valeant (VRX) is Not Investable - Piper Jaffray
Mar 21, 2016 11:07AM Valean (VRX) Changes Seen as Steps in the Right Direction - BMO Capital
Mar 21, 2016 10:00AM Mizuho Sees More Volatility for Valeant (VRX) Amid Changes
Mar 21, 2016 09:13AM Drugmaker Valeant CEO leaving as investor Ackman joins board
Mar 21, 2016 08:59AM Valeant Pharma (VRX) to Replace CEO Pearson; Adds Bill Ackman to Board
Mar 21, 2016 08:58AM Valeant Announces CEO Succession Plan And Changes To Board Of Directors; Provides Accounting And Financial Reporting Update
Mar 21, 2016 07:25AM Wall St. ends flat as recent rally spurs caution
Mar 18, 2016 05:50PM Activist hedge funds wounded by market turmoil
Mar 17, 2016 04:32PM S&P says it may cut Ackman hedge fund's rating
Mar 17, 2016 01:39PM Herbalife (HLF) Creeps Higher on Anti-Ackman Trade
Mar 17, 2016 12:05PM Bill Ackman tells CNBC Valeant (VRX) "is a problem but we know what to do."
Mar 17, 2016 12:03PM Bill Ackman tells CNBC next redemption Mid-May
Mar 17, 2016 12:02PM Bill Ackman tells CNBC 'we don't use margin leverage - never have and never will' (VRX)
Mar 17, 2016 09:31AM Pre-Open Stock Movers 03/17: (VTAE) (RSTI) (AQXP) Higher; (SXE) (ORPN) (SALT) Lower (more...)
Mar 16, 2016 06:19PM After-Hours Stock Movers 03/16: (VTAE) (RSTI) (FDX) Higher; (GES) (SALT) (JBL) Lower (more...)
Mar 16, 2016 06:02PM Ackman sells part of Mondelez stake, has no plans for other sales
Mar 16, 2016 05:28PM Ackman's Pershing Square Trims Stake in Mondelez Int'l (MDLZ) to 5.6%
Mar 16, 2016 05:10PM Valeant Pharma (VRX) Gains on Ackman Chatter
Mar 16, 2016 04:56PM Mondelez Int'l (MDLZ) Lower on Word Ackman Selling Some Stock
Mar 15, 2016 05:02PM Valeant's stock rout serves up $5.3 billion in hedge fund losses
Mar 15, 2016 03:58PM Ackman Said to Add to Valeant Pharma (VRX) Stake - Chatter
Mar 15, 2016 03:24PM Ackman's Pershing Square Said to Support Valeant Pharma (VRX) CEO Pearson; Wants More Oversight - Bloomberg
Mar 15, 2016 11:28AM Ackman's Pershing Square Said Down $666M+ This Week on Valeant Pharma (VRX) Stake
Mar 15, 2016 08:37AM Herbalife (HLF) Shelled Out ~$700,000 Last Year to Protect CEO Johnson
Mar 15, 2016 06:20AM Drugmaker Valeant faces debt default risk; shares plunge 50 percent
Mar 14, 2016 03:37PM Pershing Square Holdings, Ltd. Announces First Quarter 2016 Investor Call and Annual London Investor Meeting

View More Recent Stories View Older Stories

Nasdaq		15000.33
	+57.68	(+0.39%)

S&P 500		4486.55
	+7.02	(+0.16%)

Market Snapshot

Free News Feed